SH/EAHP 2007 Workshop - Progress in T-cell and NK cell Malignancies - title graphic

Cases by Session

Cases by Contact Submitter

Submitter Contact Information

Session: Myelodysplastic / myeloproliferative disease
Case number: 238

Submitter(s): Attilio Orazi

Clinical history
54 year-old woman with routinely discovered thrombocytosis of 774,000 x109/l. Corresponding WBC: 7.4 x109/l (Neut.74%; Lymph. 23%; other 3%). Hb: 13.6 g/dl (MCV 92 fl). Treated with HU. Six years later, she developed secondary AML and is currently in remission post induction chemotherapy.

Details of gross/microscopic pathology:
routine formalin fixation and paraffin embedding.

Immunophenotype (flow cytometry/immunohistochemistry):
Flow of the secondary leukemia: blasts positive with CD34, CD117, CD13, CD33. No histiocytic or lymphoid antigens

Cytogenetics:
isolated 5q-

Molecular analysis:
Bcr-Abl negative; JAK2-V617F mutation positive

Interesting feature(s) of submitted case:
This represents an unusual variant of myelodysplastic/myeloproliferative disorder characterized by isolated 5q- abnormality in association with a JAK2-V617F mutation. Similar cases of 5q- syndrome presenting with chronic myeloproliferative disorders-like manifestations, thrombocytosis in particular, has been reported in the past (Takasashi et al: 5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report. Am J Hematol. 2000 Jun;64(2):120-3). More recently, it has been documented that those cases are characterized by a frequency of JAK2 mutations that is higher than that seen in the nonproliferative “garden variety” 5q- syndrome (Ingram et al: Leukemia 2006;20:1319-1321).

Proposed diagnosis:
MDS/MPD, unclassifiable characterized by thrombocytosis, granulocytic proliferation in the bone marrow, associated with 5q- and JAK2 mutation.

Panel diagnosis:
agree with proposed diagnosis

Comments:

PowerPoint:
Presentation Link

Images:
Case Image 238a.jpg Figure 1
Case Image 238b.jpg Figure 2
Case Image 238c.jpg Figure 3
Case Image 238d.jpg Figure 4
Case Image 238e.jpg Figure 5
Case Image 238f.jpg Figure 6
Case Image 238g.jpg Figure 7
Case Image 238h.jpg Figure 8
Case Image 238i.jpg Figure 9
Case Image 238j.jpg Figure 10
Case Image 238k.jpg Figure 11
Case Image 238l.jpg Figure 12
Case Image 238m.jpg Figure 13
Case Image 238n.jpg Figure 14
Case Image 238o.jpg Figure 15
Case Image 238p.jpg Figure 16
Case Image 238q.jpg Figure 17
Case Image 238r.jpg Figure 18

Back to Top

Back to Cases by Session

Back to Cases by Contact Submitter